Diana Alaverdian

ORCID: 0000-0003-1299-7314
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Adipokines, Inflammation, and Metabolic Diseases
  • Glioma Diagnosis and Treatment
  • Immune Cell Function and Interaction
  • PARP inhibition in cancer therapy
  • Inflammasome and immune disorders
  • Neuroblastoma Research and Treatments
  • Venous Thromboembolism Diagnosis and Management
  • RNA Interference and Gene Delivery
  • Antimicrobial Peptides and Activities
  • Cancer therapeutics and mechanisms
  • Respiratory viral infections research
  • interferon and immune responses
  • Drug Transport and Resistance Mechanisms
  • Genetics and Neurodevelopmental Disorders
  • Amyotrophic Lateral Sclerosis Research
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Aluminum toxicity and tolerance in plants and animals
  • Dermatological and Skeletal Disorders
  • Toxin Mechanisms and Immunotoxins
  • Biochemical and Structural Characterization
  • Liver Disease Diagnosis and Treatment
  • Machine Learning in Bioinformatics
  • Heavy Metal Exposure and Toxicity

University of Siena
2019-2023

City Hospital No. 40
2019

Stefania Mantovani Sergio Daga Chiara Fallerini Margherita Baldassarri Elisa Benetti and 95 more Nicola Picchiotti Francesca Fava Anna Gallí Silvia Zibellini Mirella Bruttini Maria Palmieri Susanna Croci Sara Amitrano Diana Alaverdian Katia Capitani Simone Furini Francesca Mari Ilaria Meloni Francesca Montagnani Mario Tumbarello Ilaria Rancan Massimiliano Fabbiani Barbara Rossetti Laura Bergantini Miriana d’Alessandro Paolo Cameli David Bennett Federico Anedda Simona Marcantonio Sabino Scolletta Federico Franchi Maria Antonietta Mazzei Susanna Guerrini Edoardo Conticini Luca Cantarini Bruno Frediani Danilo Tacconi Chiara Spertilli Raffaelli Marco Feri Alice Donati Raffaele Scala Luca Guidelli Genni Spargi Marta Corridi Cesira Nencioni Leonardo Croci Gian Piero Caldarelli Davide Romani Paolo Piacentini Maria Bandini Elena Desanctis Silvia Cappelli Anna Canaccini Agnese Verzuri Valentina Anemoli Manola Pisani Agostino Ognibene Alessandro Pancrazzi Maria Lorubbio Massimo Vaghi Antonella d’Arminio Monforte Federica Gaia Miraglia Raffaele Bruno Marco Vecchia Massimo Girardis Sophie Venturelli Stefano Busani Andrea Cossarizza Andrea Antinori Alessandra Vergori Arianna Emiliozzi Stefano Rusconi Matteo Siano Arianna Gabrieli Agostino Riva Daniela Francisci Elisabetta Schiaroli Francesco Paciosi Andrea Tommasi Pier Giorgio Scotton Francesca Andretta Sandro Panese Stefano Baratti Renzo Scaggiante Francesca Gatti Saverio Giuseppe Parisi Francesco Castelli Eugenia Quirós-Roldán Melania Degli Antoni Isabella Zanella Matteo Della Monica Carmelo Piscopo Mario Capasso Roberta Russo Immacolata Andolfo Achille Iolascon Giuseppe Fiorentino Massimo Carella Marco Castori Filippo Aucella

Abstract Toll-like receptors (TLR) are crucial components in the initiation of innate immune responses to a variety pathogens, triggering production pro-inflammatory cytokines and type I II interferons, which responsible for antiviral responses. Among different TLRs, TLR7 recognizes several single-stranded RNA viruses including SARS-CoV-2. We others identified rare loss-of-function variants X-chromosomal young men with severe COVID-19 no prior history major chronic diseases, that were...

10.1038/s41435-021-00157-1 article EN cc-by Genes and Immunity 2021-12-24

The polymorphism L412F in TLR3 has been associated with several infectious diseases. However, the mechanism underlying this association is still unexplored. Here, we show that a marker of severity COVID-19. This increases sub-cohort males. Impaired macroautophagy/autophagy and reduced TNF/TNFα production was demonstrated HEK293 cells transfected TLR3L412F-encoding plasmid stimulated specific agonist poly(I:C). A statistically significant survival at 28 days shown COVID-19 patients treated...

10.1080/15548627.2021.1995152 article EN cc-by-nc-nd Autophagy 2021-12-29

The clinical presentation of COVID-19 is extremely heterogeneous, ranging from asymptomatic to severely ill patients. Thus, host genetic factors may be involved in determining disease and progression. Given that carriers single cystic fibrosis (CF)-causing variants the

10.3390/jpm11060558 article EN Journal of Personalized Medicine 2021-06-15

Glioblastoma (GBM) is one of the most aggressive and lethal malignancy central nervous system. Temozolomide standard care for gliomas, frequently results in resistance to drug tumor recurrence. Therefore, further research required development effective drugs order guarantee specific treatments succeed. The aim current study was investigate effects nerve growth factor (NGF), human cathelicidin (LL-37), protegrin-1 (PG-1), temozolomide on bioenergetic function mitochondria, clonogenicity,...

10.3390/molecules27154988 article EN cc-by Molecules 2022-08-05

Brain cancer treatment, where glioblastoma represents up to 50% of all CNS malignancies, is one the most challenging calls for neurooncologists. The major driver this study was a search new approaches treatment glioblastoma. We tested live

10.3390/molecules27020569 article EN cc-by Molecules 2022-01-17

A cytokine storm, autoimmune features and dysfunctions of myeloid cells significantly contribute to severe coronavirus disease 2019 (COVID-19), caused by the acute respiratory syndrome 2 (SARS-CoV-2) infection. Genetic background host seems be partly responsible for phenotype genes related innate immune response seem critical determinants. The C9orf72 gene has a role in vesicular trafficking, autophagy regulation lysosome functions, is highly expressed involved regulating lysosomal...

10.3390/ijms22136991 article EN International Journal of Molecular Sciences 2021-06-29

Host genetics is an emerging theme in COVID-19. A handful of common polymorphisms and some rare variants have been identified, either through GWAS or candidate gene approach, respectively. However, organic model still missing. Here, we propose a that takes into account both coding variants. This has piloted cohort 1,318 Italian SARS-CoV-2 positive individuals. Ordered logistic regression clinical WHO grading on age, stratified by sex, was used to obtain binary phenotypic classification...

10.26502/fccm.92920232 article EN Cardiology and Cardiovascular Medicine 2021-01-01

Loss of function mutations in PCDH19 gene causes an X-linked, infant-onset clustering epilepsy, associated with intellectual disability and autistic features. The unique pattern inheritance includes random X-chromosome inactivation, which leads to pathological tissue mosaicism. Females carrying are affected, while males have a normal phenotype. No cure is presently available for this disease.Fibroblasts from female patient frameshift mutation were reprogrammed into human induced pluripotent...

10.1002/epd2.20065 article EN cc-by-nc-nd Epileptic Disorders 2023-04-26

Glioblastoma (GBM) is an aggressive and lethal malignancy of the central nervous system with a median survival rate 15 months. We investigated combined anticancer effects nerve growth factor (NGF), cathelicidin (LL-37), protegrin-1 (PG-1) chemotherapy (temozolomide, doxorubicin, carboplatin, cisplatin, etoposide) in glioblastoma U251 cell line to overcome limitations conventional guarantee specific treatments succeed. The MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)...

10.3390/biomedicines11113009 article EN cc-by Biomedicines 2023-11-09

ABSTRACT The polymorphism L412F in TLR3 has been associated with several infectious diseases. However, the mechanism underlying this association is still unexplored. Here, we show that a marker of severity COVID-19. This increases sub-cohort males. Impaired autophagy and reduced TNFα production was demonstrated HEK293 cells transfected TLR3-L412F plasmid stimulated specific agonist poly(I:C). A statistically significant survival at 28 days shown COVID-19 patients treated autophagy-inhibitor...

10.1101/2021.03.23.21254158 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2021-03-26

Abstract Host genetics is an emerging theme in COVID-19 and few common polymorphisms some rare variants have been identified, either by GWAS or candidate gene approach, respectively. However, organic model still missing. Here, we propose a new that takes into account germline applied cohort of 1,300 Italian SARS-CoV-2 positive individuals. Ordered logistic regression clinical WHO grading on sex age was used to obtain binary phenotypic classification. Genetic variability from WES synthesized...

10.1101/2021.01.27.21250593 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2021-01-29

Abstract According to modern classification, there are two forms of inherited ichthyoses: syndromic and non-syndromic, each them consists more than ten different nosologies. The commonest types the ichthyosis X-linked recessive (prevalence 1/2000–6000 in men) autosomal dominant, or vulgaris with incomplete penetrance (1/250–1000). form is associated mutations steroid sulfatase STS gene, it noteworthy that a full deletion gene 90% cases. Ichthyosis caused by heterozygous FLG encoding...

10.1515/dmpt-2019-0008 article EN Drug Metabolism and Personalized Therapy 2019-12-18

Abstract Thromboembolism is a frequent cause of severity and mortality in COVID-19. However, the etiology this phenomenon not well understood. A cohort 1,186 subjects, from GEN-COVID consortium, infected by SARS-CoV-2 with different were stratified sex adjusted age. Then, common coding variants whole exome sequencing mined LASSO logistic regression. The homozygosity cell adhesion molecule P-selectin gene ( SELP) rs6127 (c.1807G>A; p.Asp603Asn) which increases platelet activation found to...

10.1101/2021.05.25.21257803 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2021-05-27

Objectives Oncological diseases are an urgent medical and social problem. The chemotherapy induces not only the death of tumor cells but also contributes to development their multidrug resistance healthy tissues. In this regard, search for new pharmacological substances with anticancer activity against drug-resistant tumors is utmost importance. present study we primarily investigated correlation between expression TrkA p75 receptors nerve growth factor (NGF) cisplatin or temozolomide...

10.1515/dmdi-2020-0109 article EN Drug Metabolism and Personalized Therapy 2020-09-07

Abstract Objectives Oncological diseases are an urgent medical and social problem. The chemotherapy induces not only the death of tumor cells but also contributes to development their multidrug resistance healthy tissues. In this regard, search for new pharmacological substances with anticancer activity against drug-resistant tumors is utmost importance. present study we primarily investigated correlation between expression TrkA p75 receptors nerve growth factor (NGF) cisplatin or...

10.1515/dmpt-2020-0109 article EN Drug metabolism and drug interactions 2020-09-04

In review discusses the phenomenon of drug resistance GB in context expression ABC family transporter proteins and processes proliferation, angiogenesis, recurrence death. The emphasis is on identifying for molecular targets among growth factors, receptors, signal transduction proteins, microRNAs, transcription proto-oncogenes, tumor suppressor genes their polymorphic variants (SNPs) development creation targeted anticancer drugs.

10.37469/0507-3758-2021-67-1-20-28 article EN cc-by-nc-nd Voprosy Onkologii 2021-03-04
Coming Soon ...